Oral Agents and SARS-CoV-2 Vaccine Effectiveness Against Severe COVID-19 Omicron Events in Maintenance Dialysis Patients

What is it about?

Among maintenance dialysis patients, SARS-CoV-2 vaccines provide highest protection against severe COVID-19 events in the first three months and lowest nine to twelve months following vaccination. COVID vaccine boosters should occur at least yearly in this high-risk population. Oral COVID antiviral agents are not often used but may reduce risk for hospitalization/death from COVID-19, even in those vaccinated.

Featured Image